Get Involved
On the day

Cell & Gene Therapies: The Cures Patients Can’t Get?

Advanced therapies refer to new medical products that use gene therapy, cell therapy, and tissue engineering to treat diseases or injuries, such as skin in burns victims, Alzheimer's, cancer or muscular dystrophy, and which will have a huge impact on the future of medicine. During this session, alongside some of the experts in the field, we will delve into the current state of Advanced Therapies as well as the challenges the industry faces in bringing these life-saving treatments to patients .

Speakers


Giant Health Speaker

Jonathan Hay

Partner

Delin Ventures
Giant Health Speaker

Dr. Annalisa Jenkins

Chair Of The Board

FasterCures
Giant Health Speaker

Jason Jones

Chief Business Officer

Ori Biotech Ltd.
Giant Health Speaker

Dr. Matthew Lakelin, PhD

VP Scientific Affairs

TrakCel Ltd
Giant Health Speaker

Dr. Damian Marshall

Director - New Technologies

Cell and Gene Therapy Catapult
Giant Health Speaker

Christoph Ruedig

Partner

AlbionVC
Giant Health Speaker

Dr. Eleni Salamaxani

Commercial Partnerships Manager

Genomics England
Giant Health Speaker

Dr. Nihal Sinha

Healthcare Venture Capital

F-Prime Capital
Giant Health Speaker

Dr. Andy Walker

Commercial Development Director

Bio-Techne


Curated by

Jason C. Foster

Managing Director, Health Equity Consulting

Jason is Managing Director of Health Equity Consulting, a Non-Executive Director of GripAble & Auxita, a principal in an early stage healthTech investment vehicle, a Venture Partner at Deep Science Ventures and Co-Chair of the Tech London Advocates HealthTech group.

LinkedIn          Twitter

 

 

09:30 – 09:35

Introduction

Jason Foster, Health Equity Consulting

09:35 - 10:35

Panel A - The amazing clinical promise of advanced therapies

A discussion about the exciting advances happening in genomics, cell and gene therapies and regenerative medicine to cure cancer and genetic diseases.  This panel will discuss the cutting-edge science and the application of it in the clinic and recently in the hospital.

Moderator: Dr. Annalisa Jenkins – Milken Institute

Panellists: 

Eleni Salamaxani – Genomics England
Dr Ed Samuels - Achilles Therapeutics

Mark Lowdell – UCL/Royal Free
Nihal Sinha - F-Prime 

10:35 - 10:45

break

10:45 – 11:45

Panel B - The challenges ahead for advanced therapies

Advanced therapies, the first wave of truly personalised medicines, present unique challenges for manufacturers, payers, suppliers and providers.   This panel will discuss the challenges currently holding back advanced therapies and what can be done to ensure patients can get access to these life-saving medicines

Moderator: Jason C. Foster – Health Equity Consulting

Panellists: 
Jason Jones – Ori Biotech  

Dr Andy Walker - Bio-Techne 

Dr Damian Marshall, Cell & Gene Catapult
Dr Matthew Lakelin - TrakCel

Owen Smith - 4BIO

11:45 – 12:00

break

12:00 – 13:00

Panel C - Where are the opportunities in advanced therapies? 
There are many new opportunities for innovation in the nascent advanced therapies space and this panel will discuss where innovators and investors see specific opportunities today

Moderator: Jason C. Foster – Health Equity Consulting
Panellists:
Jonathan Hay – Delin Ventures 

Christoph Ruedig – Albion Ventures

Owen Smith - 4BIO
Mark Lowdell – UCL/Royal Free

Nihal Sinha - F-Prime 

12:40 - 13:00

Closing remarks

Jason Foster, Health Equity Consulting